Cell sensitivity assays: The MTT assay

Methods in Molecular Biology

Volumn 731, Issue , 2011, Pages 237-245

  Van Meerloo, Johan ^a   Kaspers, Gertjan J L ^a   Cloos, Jacqueline ^a  

^a NONE

Author keywords

3 4,5 Dimethylthiazol 2 yl 2,5 diphenyl tetrazolium bromide; Cytotoxicity assay; Drug sensitivity assay; MTT; Viability assay

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; CYTOTOXIN; FORMAZAN; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ASSAY; CELL POPULATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; PRIORITY JOURNAL; CELL LINE; CHEMISTRY; CULTURE TECHNIQUE; DRUG TOXICITY; METABOLISM; METHODOLOGY; PATHOLOGY; TOXICITY TESTING;

CELL CULTURE TECHNIQUES; CELL LINE; CYTOTOXINS; DRUG TOXICITY; FORMAZANS; HUMANS; TETRAZOLIUM SALTS; THIAZOLES; TOXICITY TESTS;

EID: 84934444135     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-80-5_20     Document Type: Article

References (8)

1. Kaspers, G.J., Pieters, R., Van Zantwijk, CH., Van Wering, E.R., Van Der Does-Van Den Berg, A., Veerman, A.J. (1998) Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs. Blood. 92, 259-266.
2. Salomons, G.S., Smets, L.A., Verwijs-Janssen, M., Hart, A.A., Haarman, E.G., Kaspers, G.J., Wering, E.V., Der Does-Van Den Berg, A.V., Kamps, W.A. (1999) Bcl-2 family members in childhood acute lymphoblastic leukemia: relationships with features at presentation, in vitro and in vivo drug response and long-term clinical outcome. Leukemia. 13, 1574-1580.
3. Kaspers G.J., Veerman A.J., Pieters R, Van Zantwijk CH., Smets L.A., Van Wering E.R., Van Der Does-Van Den Berg A. (1997) In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblas-tic leukemia. Blood. 90, 2723-2729.
4. Kaspers, G.J., Wijnands, J.J., Hartmann, R., Huismans, L., Loonen, A.H., Stackelberg, A., Henze, G., Pieters, R., Hählen, K., Van Wering, E.R., Veerman, A.J. (2005) Immuno-phenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia. Eur J Cancer. 41, 1300-1303.
5. Hubeek, I., Peters, G.J., Broekhuizen, R., Zwaan, C.M., Kaaijk, P., van Wering, E.S., Gibson, B.E., Creutzig, U., Janka-Schaub, G.E., den Boer, M.L., Pieters, R., Kaspers, G.J. (2006) In vitro sensitivity and cross-resistance to deoxynucleoside analogs in childhood acute leukemia. Haematologica. 91, 17-23.
6. Oerlemans, R., Franke, N.E., Assaraf, Y.G., Cloos, J., van Zantwijk, I., Berkers, C.R., Scheffer, G.L., Debipersad, K., Vojtekova, K., Lemos, C., van der Heijden, J.W., Ylstra, B., Peters, G.J., Kaspers, G.J., Dijkmans, B.A., Scheper, R.J., Jansen, G. (2008) Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein. Blood. 112, 2489-2499.
7. Klumper E., Pieters R., Veerman A.J., Huismans D.R., Loonen A.H., Hählen K., Kaspers G.J., van Wering E.R., Hartmann R., Henze G. (1995) In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia. Blood. 86, 3861-3868.
8. Kaspers G.J., Veerman A.J., Pieters R, Broekema G.J., Huismans D.R., Kazemier K.M., Loonen A.H., Rottier M.A., van Zantwijk CH., Hählen K. (1994) Mononuclear cells contaminating acute lymphoblastic leu-kaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay. Br J Cancer. 70, 1047-1052.